{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:02:25Z","timestamp":1776772945673,"version":"3.51.2"},"reference-count":21,"publisher":"Baishideng Publishing Group Inc.","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Clin Oncol"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n                  <jats:p>Outcomes of early breast cancer in African women are currently not well defined.<\/jats:p>\n                  <jats:p>AIM<\/jats:p>\n                  <jats:p>To analyze survival outcomes and prognostic factors in Moroccan women with operable breast cancer treated with multimodal therapies.<\/jats:p>\n                  <jats:p>METHODS<\/jats:p>\n                  <jats:p>We retrospectively analyzed the data of a large cohort of 400 patients diagnosed with nonmetastatic breast cancer who completed surgery, chemotherapy, and radiotherapy at the National Institute of Oncology in Rabat, from January 2001 to December 2003.<\/jats:p>\n                  <jats:p>RESULTS<\/jats:p>\n                  <jats:p>The mean age at diagnosis was 45 years (range: 22-91 years). Surgery was performed in all cases: Mastectomy in 86% and breast-conserving surgery in 14%. Most tumors (&gt; 87%) were classified as pathologic T2 stage or higher, and axillary lymph nodes were involved in 75.5% of cases. Ninety-five percent of patients completed six cycles of adjuvant chemotherapy, and all received radiotherapy. At a median follow-up of 74.5 months, the 5-year overall survival (OS) was 82.1% [95% confidence interval (CI): 78.1-86.3], and the 5-year disease-free survival was 78.1% (95%CI: 73.8-82.6). In univariate analysis, negative nodal status [pN- vs  pN+, hazard ratio (HR) = 0.34, 95%CI: 0.16-0.75; P  = 0.007] and lower American Joint Committee on Cancer (AJCC) stage (I-II vs  III, HR = 0.29, 95%CI: 0.16-0.52; P  &lt; 0.001) were significantly associated with better OS. In multivariate analysis, AJCC stage I-II vs  stage III remained the strongest predictor of improved OS (HR = 0.32, 95%CI: 0.15-0.67; P  = 0.002), followed by treatment with anthracyclines vs  cyclophosphamide, methotrexate, fluorouracil (CMF; HR = 0.58, 95%CI: 0.35-0.94; P  = 0.027).<\/jats:p>\n                  <jats:p>CONCLUSION<\/jats:p>\n                  <jats:p>Moroccan women with early breast cancer exhibited more aggressive disease compared to women in high-income countries. AJCC stage III was the strongest predictor of poorer OS, followed by chemotherapy regimen (CMF vs  anthracycline). A multimodal treatment approach, including surgery, systemic therapy, and radiotherapy, is essential to improve breast cancer outcomes.<\/jats:p>","DOI":"10.5306\/wjco.v16.i11.110687","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:52:58Z","timestamp":1763693578000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinical outcomes of early-stage breast cancer in Morocco: A cohort of 400 women"],"prefix":"10.5306","volume":"16","author":[{"given":"Nabil","family":"Ismaili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadila","family":"Guessous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaa","family":"El Majjaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62038-9"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2013.16.31.2791"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.03.016"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2021.07.009"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.839835"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-017-0124-y"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-27-17"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-5-436"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-016-0361-z"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-3-286"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-3-247"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29059"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.09.009"},{"key":"B16","doi-asserted-by":"crossref","unstructured":"Fakhro AE, Fateha BE, al-Asheeri N, al-Ekri SA. Breast cancer: patient characteristics and survival analysis at Salmaniya medical complex, Bahrain. East Mediterr Health J 1999; 430-439","DOI":"10.26719\/1999.5.3.430"},{"key":"B17","unstructured":"Missaoui N, Jaidene L, Abdelkrim SB, Abdelkader AB, Beizig N, Yaacoub LB, Yaacoubi MT, Hmissa S. Breast cancer in Tunisia: clinical and pathological findings. Asian Pac J Cancer Prev 2011; 169-172"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.21.2492"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6874-12-35"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.11.016"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35419"}],"container-title":["World Journal of Clinical Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v16\/i11\/110687.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v16\/i11\/110687.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:53:13Z","timestamp":1763693593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/2218-4333\/full\/v16\/i11\/110687.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":21,"journal-issue":{"issue":"11"},"alternative-id":["110687"],"URL":"https:\/\/doi.org\/10.5306\/wjco.v16.i11.110687","relation":{},"ISSN":["2218-4333"],"issn-type":[{"value":"2218-4333","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,24]]}}}